Novartis has received the US Food and Drug Administration (FDA) approval for its Cosentyx (secukinumab) to treat children and adolescents with enthesitis-related arthritis and psoriatic arthritis A fully human biologic, Cosentyx is developed to directly […]
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion on the usage of Johnson & Johnson’s (J&J) Covid-19 vaccine as a booster shot for adults aged […]
Gritstone bio and the Coalition for Epidemic Preparedness Innovations have expanded their agreement to develop a self-amplifying mRNA vaccine against the Omicron variant of the SARS-CoV-2 virus. SAM vaccines leverage the machinery of the body […]
Cadila Healthcare (Zydus Cadila) has filed a New Drug Application (NDA) with the Drug Controller General of India (DCGI) seeking approval for its oral therapy, Desidustat, to treat patients with chronic kidney disease (CKD)-associated anaemia, […]
The UK’s National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s dapagliflozin as a treatment for people with chronic kidney disease (CKD). The UK’s National Institute for Health and Care Excellence (NICE) has […]